273 related articles for article (PubMed ID: 9873004)
1. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
2. Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
Tong J; Oyamada H; Demaurex N; Grinstein S; McCarthy TV; MacLennan DH
J Biol Chem; 1997 Oct; 272(42):26332-9. PubMed ID: 9334205
[TBL] [Abstract][Full Text] [Related]
3. Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.
Brini M; Manni S; Pierobon N; Du GG; Sharma P; MacLennan DH; Carafoli E
J Biol Chem; 2005 Apr; 280(15):15380-9. PubMed ID: 15689621
[TBL] [Abstract][Full Text] [Related]
4. Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release.
Du GG; Khanna VK; Guo X; MacLennan DH
Biochem J; 2004 Sep; 382(Pt 2):557-64. PubMed ID: 15175001
[TBL] [Abstract][Full Text] [Related]
5. Mutations to Gly2370, Gly2373 or Gly2375 in malignant hyperthermia domain 2 decrease caffeine and cresol sensitivity of the rabbit skeletal-muscle Ca2+-release channel (ryanodine receptor isoform 1).
Du GG; Oyamada H; Khanna VK; MacLennan DH
Biochem J; 2001 Nov; 360(Pt 1):97-105. PubMed ID: 11695996
[TBL] [Abstract][Full Text] [Related]
6. Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region.
Murayama T; Kurebayashi N; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
PLoS One; 2015; 10(6):e0130606. PubMed ID: 26115329
[TBL] [Abstract][Full Text] [Related]
7. The point mutation Arg615-->Cys in the Ca2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia.
Otsu K; Nishida K; Kimura Y; Kuzuya T; Hori M; Kamada T; Tada M
J Biol Chem; 1994 Apr; 269(13):9413-5. PubMed ID: 7511586
[TBL] [Abstract][Full Text] [Related]
8. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
Avila G; Dirksen RT
J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
[TBL] [Abstract][Full Text] [Related]
9. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
10. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
Dirksen RT; Avila G
Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
[TBL] [Abstract][Full Text] [Related]
11. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
[TBL] [Abstract][Full Text] [Related]
12. A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.
Lynch PJ; Tong J; Lehane M; Mallet A; Giblin L; Heffron JJ; Vaughan P; Zafra G; MacLennan DH; McCarthy TV
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4164-9. PubMed ID: 10097181
[TBL] [Abstract][Full Text] [Related]
13. Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia.
Jiang D; Chen W; Xiao J; Wang R; Kong H; Jones PP; Zhang L; Fruen B; Chen SR
J Biol Chem; 2008 Jul; 283(30):20813-20. PubMed ID: 18505726
[TBL] [Abstract][Full Text] [Related]
14. Genotype-Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel.
Murayama T; Kurebayashi N; Ogawa H; Yamazawa T; Oyamada H; Suzuki J; Kanemaru K; Oguchi K; Iino M; Sakurai T
Hum Mutat; 2016 Nov; 37(11):1231-1241. PubMed ID: 27586648
[TBL] [Abstract][Full Text] [Related]
15. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
16. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
[TBL] [Abstract][Full Text] [Related]
17. Several Ryanodine Receptor Type 1 Gene Mutations of p.Arg2508 Are Potential Sources of Malignant Hyperthermia.
Miyoshi H; Yasuda T; Otsuki S; Kondo T; Haraki T; Mukaida K; Nakamura R; Hamada H; Kawamoto M
Anesth Analg; 2015 Oct; 121(4):994-1000. PubMed ID: 26381711
[TBL] [Abstract][Full Text] [Related]
18. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1.
Kimura T; Nakamori M; Lueck JD; Pouliquin P; Aoike F; Fujimura H; Dirksen RT; Takahashi MP; Dulhunty AF; Sakoda S
Hum Mol Genet; 2005 Aug; 14(15):2189-200. PubMed ID: 15972723
[TBL] [Abstract][Full Text] [Related]
19. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1).
Haraki T; Yasuda T; Mukaida K; Migita T; Hamada H; Kawamoto M
Anesth Analg; 2011 Dec; 113(6):1461-7. PubMed ID: 21926372
[TBL] [Abstract][Full Text] [Related]
20. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
